Daphne Koller

Daphne Koller: AI-Driven Drug Discovery Using Digital Biology | TransformX 2022

Daphne Koller: What we're learning from online education

QB3 Webinar: Daphne Koller. “Machine Learning for Identifying Translatable Biomarkers and Targets”

insitro | Daphne Koller in discussion with Parker Moss | GERS2022

Daphne Koller @ Halpernfest '23

Code to Cure: AI and the Future of Health

Daphne Koller (insitro CEO) | On reimagining medicine with machine learning and data

Machine Learning: New Approach to Drug Discovery - Daphne Koller, Founder, Insitro

Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332

Daphne Koller | Machine Learning: A New Approach to Drug Discovery | Stanford 2020

From Theory to Therapy: The Evolution of AI in Medicine with Dr. Daphne Koller

Daphne Koller: AI should not seek to replicate human cognition

Daphne Koller: Machine Learning: A New Approach to Drug Discovery

Transforming Drug Discovery using Digital Biology Daphne Koller

Machine Learning: A New Approach to Drug Discovery | Daphne Koller | WiDS 2020

New Horizons in Generative AI: Machine Learning for Translatable Drug Discovery

MIDL 2020, Keynote by Daphne Koller: Machine learning: a new approach to drug discovery

Machine learning for better medicines

BayLearn2019-12 Dr Daphne Koller

ETL Speaker Series: Daphne Koller, insitro

The Challenge of Combining Biology and Technology | Daphne Koller, Ph.D., Founder and CEO, insitro

AIMI Symposium 2020 - Keynote & Fireside Chat with Eric Topol and Daphne Koller

Daphne's Entrance into Machine Learning Applied to Biology | Daphne Koller, Ph.D., insitro

Targeting Therapeutic Hypothesis in Machine Learning | Daphne Koller, Ph.D., Founder & CEO, insitro